Comprehensive analysis of serum and tissue glycobiomarkers in chronic liver disease

Comprehensive analysis of serum and tissue glycobiomarkers in chronic liver disease - Comprehensive analysis of serum and tissue glycobiomarkers in chronic liver disease

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000030720

Enrollment

5000

Registered

2018-01-07

Start date

2017-08-16

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic liver disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Cases diagnosed as hepatitis B, hepatitis C, NAFLD

Exclusion criteria

Exclusion criteria: co-infection with HBV and HCV, other chronic liver diseases, malignant tumor

Design outcomes

Primary

Measure	Time frame
Identify glycobiomarkers associated with fibrosis progression of chronic liver disease	—

Countries

Japan

Contacts

Public ContactGoki Suda

Hokkaido University Department of gastroenterology and hepatology

gsudgast@pop.med.hokudai.ac.jp011-716-1161

Outcome results